Cargando…

The Relationship between Insomnia and the Pathophysiology of Major Depressive Disorder: An Evaluation of a Broad Selection of Serum and Urine Biomarkers

Insomnia exhibits a clinically relevant relationship with major depressive disorder (MDD). Increasing evidence suggests that insomnia is associated with neurobiological alterations that resemble the pathophysiology of MDD. However, research in a clinical population is limited. The present study, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drinčić, Tina, van Dalfsen, Jens H., Kamphuis, Jeanine, Jentsch, Mike C., van Belkum, Sjoerd M., Meddens, Marcus J. M., Penninx, Brenda W. J. H., Schoevers, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179282/ https://www.ncbi.nlm.nih.gov/pubmed/37176140 http://dx.doi.org/10.3390/ijms24098437

Ejemplares similares

Gender Differences in Developing Biomarker-Based Major Depressive Disorder Diagnostics
por: Jentsch, Mike C., et al.
Publicado: (2020)

Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression
por: Verduijn, J, et al.
Publicado: (2015)

Stability of chronotype over a 7‐year follow‐up period and its association with severity of depressive and anxiety symptoms
por: Druiven, Stella J. M., et al.
Publicado: (2020)

Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities
por: Veraart, Jolien K E, et al.
Publicado: (2021)

Interaction Between 5-HTTLPR Genotype and Cognitive Stress Vulnerability on Sleep Quality: Effects of Sub-Chronic Tryptophan Administration
por: van Dalfsen, Jens H., et al.
Publicado: (2015)

The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: A randomized placebo-controlled crossover study
por: van Dalfsen, Jens H, et al.
Publicado: (2019)

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
por: Breeksema, Joost J, et al.
Publicado: (2022)

Orbitofrontal Gray Matter Relates to Early Morning Awakening: A Neural Correlate of Insomnia Complaints?
por: Stoffers, Diederick, et al.
Publicado: (2012)

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
por: Breeksema, Joost J., et al.
Publicado: (2023)

Similar polysomnographic pattern in primary insomnia and major depression with objective insomnia: a sign of common pathophysiology?
por: Hein, Matthieu, et al.
Publicado: (2017)

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study
por: Breeksema, Joost J., et al.
Publicado: (2022)

Disturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive Episodes
por: Becking, Karlijn, et al.
Publicado: (2015)

The role of anxious distress in immune dysregulation in patients with major depressive disorder
por: Gaspersz, Roxanne, et al.
Publicado: (2017)

Mind wandering during attention performance: Effects of ADHD-inattention symptomatology, negative mood, ruminative response style and working memory capacity
por: Jonkman, Lisa M., et al.
Publicado: (2017)

The antidepressant effect and safety of non-intranasal esketamine: A systematic review
por: Smith-Apeldoorn, Sanne Y, et al.
Publicado: (2022)

Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
por: Verduijn, Judith, et al.
Publicado: (2017)

Experienced Burden of and Adherence to Smartphone-Based Ecological Momentary Assessment in Persons with Affective Disorders
por: van Genugten, Claire R., et al.
Publicado: (2020)

Metabolomics signatures of depression: the role of symptom profiles
por: de Kluiver, Hilde, et al.
Publicado: (2023)

Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2019)

Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2020)

Hyperarousal and Beyond: New Insights to the Pathophysiology of Insomnia Disorder through Functional Neuroimaging Studies
por: Kay, Daniel B., et al.
Publicado: (2017)

Treatment of insomnia based on the mechanism of pathophysiology by acupuncture combined with herbal medicine: A review
por: Wang, Jie, et al.
Publicado: (2023)

Sleep, circadian rhythm, and physical activity patterns in depressive and anxiety disorders: A 2‐week ambulatory assessment study
por: Difrancesco, Sonia, et al.
Publicado: (2019)

Predictors of the Onset of Manic Symptoms and a (Hypo)Manic Episode in Patients with Major Depressive Disorder
por: Boschloo, Lynn, et al.
Publicado: (2014)

Metabolomic profiles discriminating anxiety from depression
por: de Kluiver, Hilde, et al.
Publicado: (2021)

Insomnia
por: Broadbent, William H.
Publicado: (1900)

Broad complex rhythm with a salty taste
por: Boulaksil, M., et al.
Publicado: (2017)

Broad complex rhythm with a salty taste
por: Boulaksil, M., et al.
Publicado: (2017)

Pathophysiological Evaluation of Cerecyte Coil Embolization for Experimental Broad Neck Aneurysms
por: Iwamoto, Kazuhisa, et al.
Publicado: (2012)

Prevention programmes for children of parents with a mood/anxiety disorder: Systematic review of existing programmes and meta‐analysis of their efficacy
por: Havinga, Petra J., et al.
Publicado: (2021)

Basal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression
por: van Eeden, Wessel A., et al.
Publicado: (2020)

Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study
por: Beijers, Lian, et al.
Publicado: (2019)

Predicting the naturalistic course of depression from a wide range of clinical, psychological, and biological data: a machine learning approach
por: Dinga, Richard, et al.
Publicado: (2018)

Predicting the naturalistic course in anxiety disorders using clinical and biological markers: a machine learning approach
por: Bokma, Wicher A., et al.
Publicado: (2022)

Advances in the management of insomnia
por: Pigeon, Wilfred R., et al.
Publicado: (2014)

Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review
por: Veraart, Jolien K E, et al.
Publicado: (2021)

Sociodemographic, Health and Lifestyle, Sampling, and Mental Health Determinants of 24-Hour Motor Activity Patterns: Observational Study
por: Difrancesco, Sonia, et al.
Publicado: (2021)

The hypothalamic-pituitary-adrenal axis and the central monoaminergic systems: a pathophysiological link to insomnia with clinical implications
por: Bezerra, Marcio Luciano de Souza, et al.
Publicado: (2022)

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2021)

Anxiety sensitivity, its stability and longitudinal association with severity of anxiety symptoms
por: Hovenkamp-Hermelink, Johanna H. M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3ssl55l4073nndr23nvc3t8rcc